Peter S Grimison

18PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Predictive and prognostic markersPacific Peoples social, cultural, emotional and spiritual wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 29, 2026
A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi-Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De-Differentiated Chondrosarcoma.

Matthew Youssef, Peter Grimison

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Jul 02, 2025
Real-World Clinical Utility of Tumor Next-Generation Sequencing in Adolescent and Young Adult Patients With Sarcoma.

Karan Gupta, Peter Grimison, Karl Fernandez

|Nov 18, 2024
Real-World Outcomes of Patients Treated With Gemcitabine Using Standardized Dose and Rate and Docetaxel for Advanced Soft Tissue Sarcoma in an Australian Sarcoma Center.

Isabella Wilson, Madeleine Strach, Vivek Bhadri

|Aug 16, 2024
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.

Peter Grimison, Antony Mersiades, Adrienne Kirby

|Aug 11, 2023
Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma.

Danielle Klingberg, Susie Bae, Deborah Di-Xin Zhou

Pageof 3

Frequent Collaborators

3 joint publications

Aaron R Hansen

2 joint publications

Gedske Daugaard

2 joint publications

Helene Negaard

2 joint publications

Ugo De Giorgi